Clinical Characteristics and Prognosis in Allergic Health Workers Patients with COVID-19 Infection
Open Access
- 18 December 2024
- journal article
- Published by Brieflands in Journal of Microbiota
- Vol. 2 (1)
Abstract
Background: After a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, at the end of 2019, the cause of coronavirus disease 2019 (COVID-19) was soon recognized as a global public health emergency. Objectives: This study aimed to investigate the clinical characteristics of allergic healthcare workers (HCWs) confirmed to have COVID-19. Methods: This study included 30 HCWs with confirmed COVID-19 at Kosar Hospital in Semnan, Iran, from February to June 2020 (15 allergic and 15 non-allergic individuals). Demographic data, clinical manifestations, and laboratory findings of the subjects were recorded. Results: Total IgE, allergen-specific IgE, and anti-SARS-CoV IgG were measured in the patients' serum. The average age of the allergic and non-allergic HCWs with COVID-19 was 33 years, and 80% were female. Malaise (76.6%), fever (60%), weakness (60%), and dry cough (56.7%) were the most common symptoms. The clinical findings showed a significantly lower percentage (33.3%) of dry cough in subjects with allergic diseases. Apart from the observed difference in the mean value of total IgE between the two groups, no significant differences were found with respect to age, duration of disease, O2 saturation, and anti-SARS-CoV-2 IgG. Conclusions: Coronavirus disease 2019 symptoms did not become severe in patients with atopic diseases. Moreover, dry cough and weakness were reported by a lower percentage of allergic HCWs.Keywords
This publication has 34 references indexed in Scilit:
- COVID-19-related temporary disability in healthcare workers in Spain during the four first pandemic wavesPreventive Medicine Reports, 2024
- Risk and Protective Factors for COVID-19 Morbidity, Severity, and MortalityClinical Reviews in Allergy & Immunology, 2022
- Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 IllnessThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19European Archives of Oto-Rhino-Laryngology, 2020
- Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort studyJournal of Allergy and Clinical Immunology, 2020
- Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19Journal of Allergy and Clinical Immunology, 2020
- Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in ChinaJournal of Allergy and Clinical Immunology, 2020
- COVID-19 and Asthma: Reflection During the PandemicClinical Reviews in Allergy & Immunology, 2020
- Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problemsInfection Control & Hospital Epidemiology, 2020
- Eosinophils: Friends or Foes?The Journal of Allergy and Clinical Immunology: In Practice, 2018